Ann‐Kathrin Eisfeld

Leukemia Research Foundation — United States

Medicine · Health Sciences

31h-index2.6kcitations267works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(181), Chronic Myeloid Leukemia Treatments(45), Myeloproliferative Neoplasms: Diagnosis and Treatment(42), Cancer Genomics and Diagnostics(35), Acute Lymphoblastic Leukemia research(30)

Publications267 total

circPCMTD1: A protein-coding circular RNA that regulates DNA damage response in BCR/ABL1-positive leukemias
Blood·2026
Cancer mortality rates by detailed occupation among US working-age adults between 2020 and 2023: a population-based study
The Lancet Oncology·2025
Real‐world analysis of <scp>CPX</scp> ‐351 in <scp>AML</scp> ‐ <scp>MR</scp> : A multicentre study from the <scp>MARROW</scp> consortium
British Journal of Haematology·2025Open Access
A multicenter real-world study on response and survival in older patients with acute myeloid leukemia treated with intensive chemotherapy versus VEN/HMA by 2022 and 2024 ELN risk stratifications: An analysis from the MARROW consortium
Blood·2025Open Access
Accounting for long-term survivors and population-expected survival improves survival outcomes estimation and prediction in older patients with core-binding factor (CBF) Acute Myeloid Leukemia (AML)
Blood·2025Open Access
Defining the clinical characteristics and outcomes of adult patients (pts) with 11q23/KMT2A-rearranged Acute Myeloid Leukemia (AML): An analysis from the MARROW consortium
Blood·2025Open Access
Increased yield of recurrent structural variants (SVs) in Ph-like B-cell acute lymphoblastic leukemia (B-ALL) using a streamlined clinical whole-genome sequencing (WGS) assay
Blood·2025Open Access
Tri-partied analyses define clinical outcomes and molecular features of patients (pts) with acute promyelocytic leukemia (APL)
Blood·2025
Deep learning predicts IDH1 mutation status in Acute Myeloid Leukemia from bone marrow smear images
Blood·2025
Impact of modernizing eligibility criteria on enrollment and representation in acute myeloid leukemia clinical trials
Blood·2025· 2 cited
Prognostic and Therapeutic Implications of <i>BRAF</i> Mutations in Acute Myeloid Leukemia
2025Open Access
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML
Blood Neoplasia·2025Open Access
Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group &amp; Alliance for Clinical Trials in Oncology)
Leukemia·2025· 1 citedOpen Access
POSTER: AML-488 A Phase 1 Study of Gemtuzumab Ozogamicin Added to Cytarabine, Daunorubicin, and Midostaurin Induction in Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia·2025
AML-488: A Phase 1 Study of Gemtuzumab Ozogamicin Added to Cytarabine, Daunorubicin, and Midostaurin Induction in Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia·2025
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults
Blood Cancer Journal·2025· 4 citedOpen Access
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States
Blood Cancer Discovery·2025· 1 citedOpen Access
Figure 1 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025Open Access
Data from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025Open Access
Figure 3 from Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q
2025Open Access
page 1 of 14Next →

Frequent Co-authors

Krzysztof Mrózek(27), Deedra Nicolet(27), Jessica Kohlschmidt(25), Richard M. Stone(25), Clara D. Bloomfield(25), Jonathan E. Kolitz(23), Christopher J. Walker(22), Andrew J. Carroll(21), John C. Byrd(21), Bayard L. Powell(19), James S. Blachly(17), Albert de la Chapelle(16), Shelley Orwick(13), Guido Marcucci(12), Sebastian Schwind(11), Christopher C. Oakes(10), Ramiro Garzon(9), Dimitrios Papaioannou(9), Alice S. Mims(9), Geoffrey L. Uy(8)